Obstetrics & Gynecology Doctors in Knoxville, IA - Medicare Status, Address, Contact

1 Obstetrics & Gynecology doctors found. Showing 1 - 1

Mitchell Alan Khan, D.O.
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 410 E Robinson St, Suite B2, Knoxville, IA 50138
Phone: 641-842-3700 Fax: 641-842-3363

News Archive

Proposed Medicare payment changes for hospitals would lower reimbursements slightly

The Wall Street Journal: "Hospital stocks moved higher Tuesday after the agency that runs Medicare proposed new inpatient services rates for the next fiscal year that were somewhat better than many had expected. Monday evening the Centers for Medicare & Medicaid Services said it would like to cut Medicare operating payments to acute care hospitals for inpatient services occurring in the next fiscal year by $142 million, or 0.1%. These figures don't include the impact of the new health-care reform law, which analysts said would cut the rate by another 0.25%".

Folic acid supplement may improve blood flow in young amenorrheic runners

A study led by sports medicine researcher Anne Hoch, D.O. at The Medical College of Wisconsin in Milwaukee has found that oral folic acid may provide a safe and inexpensive treatment to improve vascular function in young female runners who are amenorrheic (not menstruating).

Will Obama jobs plan undercut health sector's jobs growth?

Health care providers are warning that President Barack Obama's new jobs plan could actually siphon jobs from one of the few industries still hiring -; because the only way to pay for it would be to make deeper cuts in the health care entitlement programs (Dobias, 9/11).

UK Court passes verdict in favor of Lilly relating to Alimta vitamin regimen patent claim

Eli Lilly and Company today announced that the Court of Appeal has ruled that the Alimta® (pemetrexed disodium) vitamin regimen patent would be indirectly infringed by a generic competitor that had stated its intent to market certain alternative salt forms of pemetrexed in the United Kingdom prior to the UK patent's expiration in June 2021.

Janssen enrolls patients in expanded access program for mantle cell lymphoma

Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.

Obstetrics & Gynecology Doctors in Knoxville, IA Accepting Medicare